Elevance PT receives Investment Bank Analyst Rating Update
Elevance Health Inc. (ELV) reported Q2 EPS of $8.04, $0.30 better than the analyst estimate of $7.74. Revenue for the quarter came in at $38.5 billion versus the consensus estimate...
By Sam BougheddaMorgan Stanley analyst Ricky Goldwasser said in a client note Wednesday that the firm is upgrading Cigna Corporation (NYSE:CI) shares to Overweight from Equal...
The consumer is holding up despite surging inflation. A hot jobs market helpsAn equal-weight basket of retail stocks has plunged 30% this year as a pessimistic outlook...
Elevance Health, Inc., formerly Anthem, Inc., is a health company. It is focused on whole health. It supports health at every life stage, offering health plans and clinical, behavioral, pharmacy and complex-care solutions that promote whole health. It identifies the resources needed to support residents, including the people it serves, and ensure those resources meet local needs. It focuses on advancing health equity, such as ensuring people with disabilities and rural residents can find accessible care. Additionally, it also focuses on prioritizing three areas, such as maternal health, behavioral health, and access to evidence-based medical therapy. It also focuses on providing digitally enabled healthcare. It provides a consumer-centered health system. Carelon is its healthcare services brand and Wellpoint is its health plan brand. Its other brands include Anthem Blue Cross and Blue Shield. Through these brands, it focuses on delivering solutions beyond traditional health insurance.